SCHEMBL6520358

SCHEMBL6520358

C=Cc1c(C=O)cccc1-c1ccc(Cl)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.40
PTGS1 P23219 1/20 0.40
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 3/20 0.35
XDH P47989 2/20 0.35
PARP1 P09874 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 1/20 0.34
THRB P10828 1/20 0.34
BLM P54132 1/20 0.34
ALDH1A1 P00352 3/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
ERN1 O75460 4/20 0.34
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11353727 0.84 KMT2A (0.43) PTGS2HSD17B10TDP1XDHMEN1
SCHEMBL6525704 0.84 CHRM1 (0.38) TDP1MEN1KMT2AERN1GAA
SCHEMBL387189 0.78 XDH (0.51) PTGS2PTGS1HSD17B10TDP1XDH
SCHEMBL6518492 0.78 ALDH1A1 (0.47) HSD17B10TDP1MEN1KMT2ALMNA
SCHEMBL9990065 0.77 PTGS2 (0.40) PTGS2PTGS1HSD17B10TDP1XDH
SCHEMBL2360182 0.77 ERN1 (0.44) PTGS2PTGS1HSD17B10TDP1XDH
SCHEMBL547471 0.76 PTGS2 (0.39) PTGS2PTGS1HSD17B10TDP1XDH
SCHEMBL5735298 0.76 ERN1 (0.52) PTGS2PTGS1HSD17B10SLC6A4SLC6A3
SCHEMBL27671900 0.75 SLC6A4 (0.46) PTGS2PTGS1TDP1PARP1SLC6A4
SCHEMBL7760471 0.74 ALDH1A1 (0.50) PTGS2PTGS1HSD17B10ALDH1A1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680150-B2 Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors LIGAND PHARMACEUTICALS, INC. (US) 2014-03-25 US disclosed
US-20110003851-A1 SMALL MOLECULE HEMATOPOIETIC GROWTH FACTOR MIMETIC COMPOUNDS THAT ACTIVATE HEMATOPOIETIC GROWTH FACTOR RECEPTORS LIGAND PHARMACEUTICALS, INC. (US) 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003851-A1 SMALL MOLECULE HEMATOPOIETIC GROWTH FACTOR MIMETIC COMPOUNDS THAT ACTIVATE HEMATOPOIETIC GROWTH FACTOR RECEPTORS MPL, CSF3R, CSF1R PTGS2 1685/4885PTGS1 1160/4885HSD17B10 4499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.